Peroxide Or Compositions Of Or Releasing Gaseous Oxygen Or Ozone Patents (Class 424/613)
-
Publication number: 20140120178Abstract: The present invention provides a multi-component encapsulated reactive formulation comprising a mixture of two or more dry powder components, where each dry powder component is formed from a phase inversion process involving vigorous mixing. The dry powder is stabilized by hydrophobic colloidal particles, which assist in generating stable “dry water” microdroplets. One dry powder component comprises hydrophobic colloidal particles encapsulating microdroplets comprising an aqueous solution of one reactant, and the at least one other dry powder component comprises hydrophobic colloidal particles encapsulating microdroplets comprising an aqueous solution of another reactant. When the encapsulated formulation is agitated such that the encapsulates are broken, the encapsulates rupture and the two aqueous solutions undergo a reaction upon contact.Type: ApplicationFiled: October 25, 2013Publication date: May 1, 2014Applicant: Pibed LimitedInventors: John David Hines, Bernard Paul Binks, Pierre Bruno Grascha
-
Publication number: 20140120153Abstract: The present invention comprises methods and compositions for delivery devices More particularly, the present invention comprises methods and compositions for devices comprising a matrix comprising a polymer network and a non-gellable polysaccharide having oxygen and optionally active agents incorporated therein. The matrix may be formed into any desired shape for treatment of compromised tissue or for delivery of oxygen to a localized environment.Type: ApplicationFiled: January 8, 2014Publication date: May 1, 2014Applicant: Kimberly-Clark Worldwide, Inc.Inventors: Bruce L. Gibbins, Lance D. Hopman
-
Publication number: 20140099384Abstract: The invention relates to improvements in apparatus and methods for producing ozone. The apparatus comprises: a differential pressure injector, a means for circulating aqueous fluid through the differential pressure injector and programmable control means. An ozone generator is provided for connection to an oxygen source via an oxygen delivery conduit and a first valve means is located in the oxygen delivery conduit. The ozone generator is fluidly connected to the differential pressure injector via an ozone delivery conduit and second valve means are located in the ozone delivery conduit. Pressure monitoring means are located between the ozone generator and the first valve means for providing a pressure measurement to the control means. The valve means and the fluid circulation means are operable to create a negative pressure in the oxygen and ozone delivery conduits and the pressure measurement is used by the control means to determine the integrity of the oxygen and ozone delivery conduits.Type: ApplicationFiled: May 14, 2012Publication date: April 10, 2014Inventors: Allan Kenneth Frazer Grugeon Hunt, John George Chewins
-
Publication number: 20140099375Abstract: Provided are electrokinetically-altered aqueous fluids (e.g., gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for use in treating an irritation, infection or inflammatory eye condition, comprising administering to, by contacting the eye of a subject in need thereof a therapeutically effective amount of an electrokinetically-altered aqueous fluid. The electrokinetically-altered fluids or therapeutic compositions and methods include electrokinetically-altered ioinic aqueous fluids optionally in combination with other therapeutic agents. Other embodiments include particular routes of administration or formulations for the electrokinetically-altered fluids (e.g.Type: ApplicationFiled: December 11, 2013Publication date: April 10, 2014Applicant: Revalesio CorporationInventors: Gregory J. Archambeau, Anthony B. Wood, Richard L. Watson
-
Publication number: 20140086968Abstract: The present invention provides a chemical composition comprised of hydrogen peroxide and a nanoemulsion of long-chained alcohols which in combination these constituents act synergistically boost the kill-time rate of hydrogen peroxide. The peroxide based nanoemulsion formulation for application to skin includes a cosmetically approved peroxide containing compound present in a range to give from about 0.1 to about 4 wt./wt. % released hydrogen peroxide, an organic acid present in a concentration from about 0.01 to about 5 wt./wt. % for adjusting a pH of the formulation in a range from about pH 1 to about pH 4, a long-chained (C9 to C22) aryl and/or alkl alcohol, present in a concentration from about 0.1 to about 20 wt./wt. %, and an emollient present in a concentration from about 0.1 to about 40 wt./wt. %, and an emulsifier present in a concentration from about 0.1 to about 20 wt./wt. % to render the formulation a nanoemulsion.Type: ApplicationFiled: March 2, 2011Publication date: March 27, 2014Inventors: Pierre Grascha, Mylene Battut
-
Publication number: 20140086963Abstract: Particular embodiments disclosed herein relate to gas-enriched fluids, methods of making the same, systems for making the same and/or methods of treatment utilizing the gas-enriched fluids for wound care related conditions and/or diseases. In certain embodiments, the gas-enriched fluid is oxygen-enriched water. Certain embodiments relate to cosmetic and/or therapeutic fluids and/or methods of treatment utilizing the fluids in order to treat a cosmetic and/or therapeutic symptom of wound care and/or increase proper wound healing.Type: ApplicationFiled: November 26, 2013Publication date: March 27, 2014Applicant: Revalesio CorporationInventors: Gregory J. Archambeau, Richard L. Watson, Anthony B. Wood
-
Patent number: 8673365Abstract: A neutral pH aqueous ready-to-use cleaning and disinfectant compositions include hydrogen peroxide as an active disinfecting constituent including a C1-C6 monohydric alcohol, and a surfactant or surfactant mixture. Methods of cleaning and disinfecting surfaces are also disclosed.Type: GrantFiled: January 4, 2008Date of Patent: March 18, 2014Assignee: Arkema Inc.Inventors: Xue Wang, Keith R. Genco
-
Publication number: 20140072654Abstract: The present invention demonstrates the therapeutic use of ketone esters for seizure disorders, Alzheimer's disease malignant brain cancer, and other cancers, which are associated with metabolic dysregulation. The administration of a ketogenic diet, such as ketone esters, while concurrently subjecting the patient to a hyperbaric, oxygen-enriched environment resulted in therapeutic ketosis. Optionally, the hyperbaric, oxygen-enriched environment is 100% oxygen at 2.5 ATA absolute. The ketone esters may be derived from acetoacetate and can include R,S-1,3-butanediol acetoacetate monoester, R,S-1,3-butanediol acetoacetate diester, or a combination of the two. The treatment may further include administering at least 10% ketone supplementation, such as acetoacetate, adenosine monophosphate kinase, 1,3-butanediol, or ketone ester, to the patient.Type: ApplicationFiled: November 12, 2013Publication date: March 13, 2014Applicants: SAVIND, INC., UNIVERSITY OF SOUTH FLORIDAInventors: Dominic Paul D'Agostino, Patrick Arnold, Angela Marie Poff
-
Publication number: 20140072653Abstract: Systems and methods for generating reactive oxygen species formulations useful in various oxidation applications. Exemplary formulations include singlet oxygen or superoxide and can also contain hydroxyl radicals or hydroperoxy radicals, among others. Formulations can contain other reactive species, including other radicals. Exemplary formulations containing peracids are activated to generate singlet oxygen. Exemplary formulations include those containing a mixture of superoxide and hydrogen peroxide. Exemplary formulations include those in which one or more components of the formulation are generated electrochemically. Formulations of the invention containing reactive oxygen species can be further activated to generate reactive oxygen species using activation chosen from a Fenton or Fenton-like catalyst, ultrasound, ultraviolet radiation or thermal activation.Type: ApplicationFiled: September 7, 2013Publication date: March 13, 2014Applicant: CLEAN CHEMISTRY, LLCInventor: Wayne BUSCHMANN
-
Publication number: 20140050801Abstract: A gas dissolving apparatus that combines a gas at first pressure into a working fluid, the working present at a second pressure equal to or greater than the first pressure.Type: ApplicationFiled: April 26, 2011Publication date: February 20, 2014Applicant: G TECH LICENSING, LLCInventor: Caius Araujo Martins de Camargo
-
Publication number: 20140050800Abstract: Methods of ameliorating cellular oxidative stress and reducing serum cholesterol are disclosed.Type: ApplicationFiled: September 9, 2013Publication date: February 20, 2014Inventors: David Nieman, Andrew Swick, Mark Snyder, Bristol Sorensen
-
Publication number: 20140030356Abstract: There is provided a method for treating pulmonary hypertension in a subject, comprising: administering to the subject in need thereof a daily dose of ambrisentan from 1 mg to about 15 mg, wherein the method is carried out without drug labeling instruction to monitor liver aminotransferase levels during ambrisentan treatment.Type: ApplicationFiled: July 30, 2013Publication date: January 30, 2014Applicant: Gilead Sciences, Inc.Inventors: Hunter Campbell Gillies, Tobias Peschel, David J. Pizzuti
-
Patent number: 8636987Abstract: A method of whitening a tooth surface including contacting the surface of a tooth with an efficacious amount of a substantially non-cytotoxic composition. The non-cytotoxic composition includes chlorine dioxide and no more than about 0.25 milligrams oxy-chlorine anions per gram of the composition.Type: GrantFiled: July 14, 2009Date of Patent: January 28, 2014Assignee: BASF CorporationInventors: Barry Keven Speronello, Frank S. Castellana, Linda Hratko
-
Patent number: 8632821Abstract: The invention relates to a gaseous mixture containing oxygen (O2) and a volume proportion of 20 to 70% of xenon (Xe) for use as an inhalable drug for preventing or treating hypersensitivity to pain in humans or animals, in particular hypersensitivity to pain expressed as hyperalgesia or allodynia.Type: GrantFiled: July 13, 2010Date of Patent: January 21, 2014Assignees: L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude, Université Bordeaux SegalenInventors: Baptiste Bessiere, Guy Simonnet
-
Patent number: 8628788Abstract: Novel formulations containing a non-oxidative biocide, such as DBNPA, and a source of an in situ produced active biocide, such as a concentrated aqueous solution of an inorganic halide salt, are disclosed. These novel formulations are particularly effective in the treatment of water, and are characterized by high stability, desirable rheological properties and an excellent biocidal activity.Type: GrantFiled: February 25, 2007Date of Patent: January 14, 2014Assignee: Bromine Compounds, Ltd.Inventors: David Feldman, Michel Adda, Raymond J. Roccon
-
Publication number: 20140010848Abstract: Compressible and concentrated suspensions containing gas-filled microbubbles, uses thereof for delivering gas into a subject in need thereof, and systems for delivering the compressible suspensions. The gas-filled microbubbles each comprise a gas core surrounded by a lipid membrane, which includes (a) one or more lipids, such as 1,2-disteroyl-sn-glycero-3-phosphocholine (DSPC) or dipalmitoylphosphatidylcholine (DPPC), and (b) one or more stabilizing detergents, such as poloxamer 188, Pluronic F108, Pluronic F127, polyoxyethylene (100) stearyl ether, cholesterol, gelatin, polyvinylpyrrolidone (PVP), and sodium deoxycholate (NaDoc).Type: ApplicationFiled: November 11, 2011Publication date: January 9, 2014Applicant: Children's Medical Center CorporationInventors: John Kheir, Francis X. McGowan, Andrew Loxley, Robert Lee
-
Patent number: 8623392Abstract: An allergen inactivating agent for preventing allergic manifestations or alleviating symptoms by reducing antigenicity of an allergen through contact with the allergen includes dissolved chlorine dioxide as an active ingredient.Type: GrantFiled: February 15, 2008Date of Patent: January 7, 2014Assignee: Taiko Pharmaceutical Co., Ltd.Inventors: Hirofumi Morino, Takashi Shibata
-
Patent number: 8617616Abstract: Provided are electrokinetically-altered fluids (e.g., gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for use in treating a wound to a surface tissue or a symptom thereof. The electrokinetically-altered fluids or therapeutic compositions and methods include electrokinetically-altered ionic aqueous fluids optionally in combination with other therapeutic agents. Particular aspects provide for regulating or modulating intracellular signal transduction associated with said inflammatory responses by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e.g.Type: GrantFiled: April 28, 2009Date of Patent: December 31, 2013Assignee: Revalesio CorporationInventors: Gregory J. Archambeau, Richard L. Watson, Anthony B. Wood
-
Patent number: 8617647Abstract: An adhesive composition is provided that is water-insoluble yet water-absorbent, i.e., capable of absorbing up to 15 wt. % water or more. The composition in composed of a film-forming hydrophilic polymer with at least one linear segment having a plurality of recurring polar groups along the polymer backbone, a complementary multifunctional polymer with a plurality of recurring functional groups that noncovalently bind to the polar groups on the film-forming polymer, and plasticizer. A method for manufacturing the adhesive composition is provided as well.Type: GrantFiled: August 24, 2012Date of Patent: December 31, 2013Assignees: A.V. Topchiev Institutes of Petrochemical Synthesis, Russian Academy of Sciences, Corium International, Inc.Inventors: Mikhail M. Feldstein, Danir F. Bairamov, Mikhail Borisovich Novikov, Valery G. Kulichikhin, Nicolai A. Platé, Gary W. Cleary, Parminder Singh
-
Publication number: 20130337069Abstract: Quantum active sized silicon nanoparticles with a silicon core covered by a thin 0.5-1.5 nm oxide/nitride shell are described for light exposure in the 300-600 nm range for transforming atmospheric oxygen to singlet oxygen for causing cell apoptosis as a type of photodynamic cancer therapy. A method of use of the nanoparticle in a non-hydrophobic cream is also taught along with a blocking scheme for controlled reaction of the nanoparticle.Type: ApplicationFiled: July 3, 2013Publication date: December 19, 2013Inventors: James Beckman, Anatoli Ischenko
-
Patent number: 8609148Abstract: Provided are electrokinetically-altered aqueous fluids (e.g., gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for use in treating an irritation, infection or inflammatory eye condition, comprising administering to, by contacting the eye of a subject in need thereof a therapeutically effective amount of an electrokinetically-altered aqueous fluid. The electrokinetically-altered fluids or therapeutic compositions and methods include electrokinetically-altered ioinic aqueous fluids optionally in combination with other therapeutic agents. Other embodiments include particular routes of administration or formulations for the electrokinetically-altered fluids (e.g.Type: GrantFiled: April 28, 2009Date of Patent: December 17, 2013Assignee: Revalesio CorporationInventors: Gregory J. Archambeau, Anthony B. Wood, Richard L. Watson
-
Patent number: 8597689Abstract: Particular embodiments disclosed herein relate to gas-enriched fluids, methods of making the same, systems for making the same and/or methods of treatment utilizing the gas-enriched fluids for wound care related conditions and/or diseases. In certain embodiments, the gas-enriched fluid is oxygen-enriched water. Certain embodiments relate to cosmetic and/or therapeutic fluids and/or methods of treatment utilizing the fluids in order to treat a cosmetic and/or therapeutic symptom of wound care and/or increase proper wound healing.Type: GrantFiled: October 25, 2007Date of Patent: December 3, 2013Assignee: Revalesio CorporationInventors: Gregory J. Archambeau, Richard L. Watson, Anthony B. Wood
-
Patent number: 8591958Abstract: A concentrated and one phase cleaning and disinfecting solution containing a sparingly soluble cyclic carboxylic acid. The solution has a pH of from about 0.05 to about 2, and comprises, consists essentially of, or consists of from about 2% w/w to about 8% w/w hydrogen peroxide; from about 5% w/w to about 20% w/w linear alkyl benzene sulfonic acid; from about 0.5% w/w to about 8% w/w of at least one sparingly soluble (i.e. a solubility in pure water at room temperature of less than 1% w/w) cyclic carboxylic acid, wherein the cyclic carboxylic acid is present in acid and salt form in a ratio of at least 9:1 (acid:salt); from about 2% w/w to about 10% w/w of at least one block copolymer surfactant (e.g. PLURONIC L62); and from about 4% w/w to about 15% w/w of at least one solvent.Type: GrantFiled: September 30, 2009Date of Patent: November 26, 2013Assignee: Virox Technologies Inc.Inventor: Navid Omidbakhsh
-
Patent number: 8591957Abstract: Particular embodiments disclosed herein relate to electrokinetically altered gas-enriched fluids, methods of making the same, systems for making the same and/or methods of treatment utilizing the gas-enriched fluids for eye related conditions and/or diseases. In certain embodiments, the electrokinetically altered gas-enriched fluid is oxygen-enriched water. Certain embodiments relate to cosmetic and/or therapeutic fluids and/or methods of treatment utilizing the fluids to treat a cosmetic and/or therapeutic symptom related to eye conditions and/or diseases.Type: GrantFiled: October 25, 2007Date of Patent: November 26, 2013Assignee: Revalesio CorporationInventors: Gregory J. Archambeau, Anthony B. Wood, Richard L. Watson
-
Patent number: 8580233Abstract: A method of whitening a tooth surface including contacting the surface of a tooth with an efficacious amount of a substantially non-cytotoxic composition. The non-cytotoxic composition includes chlorine dioxide and no more than about 0.25 milligrams oxy-chlorine anions per gram of the composition.Type: GrantFiled: July 14, 2009Date of Patent: November 12, 2013Assignee: BASF CorporationInventors: Barry Keven Speronello, Frank S. Castellana, Linda Hratko
-
Publication number: 20130295144Abstract: Provided are electrokinetically-altered fluids (e.g., gas-enriched (e.g., oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity. Further provided are the methods of making the electrokinetically-altered ionic aqueous fluid compositions. Particular aspects provide for regulating or modulating intracellular signal transduction associated by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e.g., tight junctions, gap junctions, zona adherins and desmasomes). Other embodiments include particular methods of producing the electrokinetically-altered fluids.Type: ApplicationFiled: March 27, 2013Publication date: November 7, 2013Inventors: Anthony B. Wood, Gregory J. Archambeau, Richard L. Watson
-
Patent number: 8574605Abstract: The invention includes convenient methods of preparing: (1) highly concentrated liquid bromine-containing biocidal solutions, (2) highly concentrated mixed halogen liquid bromine and chlorine-containing biocidal solutions, and (3) high-activity bromine-containing biocidal solids, all having excellent physical and chemical stability. One method yields solutions that have concentrations of bromine in excess of 18% as Br2 (8% as Cl2) in which the mole ratio of hydroxide ion to hydrogen ion source is at least 1.9:1. Another method employs elemental bromine in conjunction with a solid organic or inorganic halogenating agent to yield halogen solutions at concentrations greater than 22.9% as Br2 (10.2% as Cl2). This method can be performed under conditions that exceed the solubility of the active ingredient such that it crystallizes and is recovered as a hydrated or anhydrous salt in good yield.Type: GrantFiled: October 19, 2007Date of Patent: November 5, 2013Assignee: Enviro Tech Chemical Services, Inc.Inventors: Jonathan N. Howarth, Michael S. Harvey
-
Patent number: 8574632Abstract: The invention provides a liquid composition containing (a) an acidic oxidant, (b) nitric acid or a salt thereof, and (c) at least one carboxylic acid selected from the group consisting of monocarboxylic acids, dicarboxylic acids, and tricarboxylic acids, or a salt thereof. The liquid composition can be used to disinfect or sterilize a subject that includes a portion made of an aluminum-based metal.Type: GrantFiled: February 19, 2009Date of Patent: November 5, 2013Assignee: Saraya Co., Ltd.Inventors: Emiko Kawamukai, Satomi Sakai, Taro Furuta
-
Publication number: 20130287861Abstract: The present application relates to novel antimicrobial compositions and methods of using said antimicrobial compositions for inhibiting and treating microbial growth, microbial infections, inflammatory diseases, viral diseases, cardiovascular diseases, diabetes and/or conditions that may be regulated or associated with microbial infections, such as cancer.Type: ApplicationFiled: July 2, 2013Publication date: October 31, 2013Inventors: Patrick O. Tennican, L. Myles Phipps
-
Patent number: 8562860Abstract: A method for activating hydrogen molecules dissolved in water and stabilizing the concentration of the hydrogen molecules is provided. The method for activating and stabilizing hydrogen molecules dissolved in water is characterized by allowing hydrogen ions to coexist with the hydrogen molecules.Type: GrantFiled: July 5, 2007Date of Patent: October 22, 2013Assignee: Spring Co., Ltd.Inventor: Osao Sumita
-
Patent number: 8540971Abstract: Oral care compositions comprising: (a) a peroxide complex comprising a peroxide component and an N-vinyl heterocyclic polymer (e.g., poly-N-vinyl polylactam, or poly-N-vinyl-polyimide); (b) a whitening agent (e.g., hydrogen peroxide); and (c) an orally acceptable carrier. In one embodiment, the carrier comprises a film forming material. Methods are also provided for making an oral care composition comprising: (a) mixing a whitening agent, silicone adhesive and carrier fluid to form a homogenous mixture; (b) adding a peroxide complex to said homogenous mixture, wherein said complex comprises hydrogen peroxide and an N-vinyl heterocyclic polymer; and (c) mixing under vacuum.Type: GrantFiled: February 25, 2008Date of Patent: September 24, 2013Assignee: Colgate-Palmolive CompanyInventors: Lynette Zaidel, Guisheng Pan, Suman K. Chopra, Prakasarao Mandadi, Michael Prencipe
-
Publication number: 20130236563Abstract: Methods of ameliorating cellular oxidative stress are disclosed.Type: ApplicationFiled: April 5, 2013Publication date: September 12, 2013Applicant: Reoxcyn Discoveries Group, IncInventors: Gary Samuelson, Verdis Norton
-
Publication number: 20130230602Abstract: Methods and devices for treating patients using high partial pressures of dissolved gas in a liquid. Greater than hyperbaric partial pressures of gas may be dissolved and maintained in the liquid when mixing occurs at ambient pressure. Additional increases in dissolved gas partial pressure may be achieved when the temperature of the liquid is further decreased. The method further includes administering the liquid intravenously via a conventional catheter. Gas exchange occurs due to diffusion upon mixing of the liquid and blood within the vasculature of the patient.Type: ApplicationFiled: March 1, 2012Publication date: September 5, 2013Applicant: OUTCOME SOLUTIONS, LLCInventors: Daniel J. Grady, Johnny Harold Riggs
-
Publication number: 20130224306Abstract: There is provided a method for treating pulmonary hypertension in a subject, comprising: administering to the subject in need thereof a daily dose of ambrisentan from 1 mg to about 15 mg, wherein the method is carried out without drug labeling instruction to monitor liver aminotransferase levels during ambrisentan treatment.Type: ApplicationFiled: June 28, 2012Publication date: August 29, 2013Applicant: Gilead Sciences, Inc.Inventors: Hunter Campbell Gillies, Tobias Peschel, David J. Pizzuti
-
Patent number: 8518456Abstract: Disclosed are compositions related to a substantially non-cytotoxic chlorine dioxide solution. The solution may be a thickened fluid composition. Also disclosed are methods of making and using a substantially non-cytotoxic thickened fluid compositions or solutions comprising chlorine dioxide solution. An oxidizing composition of reduced irritation is also disclosed.Type: GrantFiled: July 14, 2009Date of Patent: August 27, 2013Assignee: BASF CorporationInventors: Barry Keven Speronello, Frank S. Castellana, Linda Hratko
-
Publication number: 20130209575Abstract: A multi-part kit system comprising (i) a solid part A which comprises 10 to 80 wt. % of peroxy compound selected from the group consisting of KHSO5, K2S2O8, Na2S2O8, magnesium monoperoxyphthalate hexahydrate, sodium percarbonate and sodium perborate, 0.1 to 10 wt. % of LiCl, NaCl and/or KCl and 1 to 20 wt. % of H2N(CH2)nSO3H with n=0, 1, 2 or 3, and (ii) a liquid part B in the form of an aqueous solution which comprises 0 to 20 wt. % of nonionic surfactant, 3.6 to 20 wt. % of amphoteric surfactant and 0.5 to 20 wt. % of at least one compound comprising substituted ammonium selected from the group consisting of dihydrocarbyl dimethylammonium chlorides or bromides, didecyl methyl-poly(oxyethyl)ammonium propionate, chlorhexidine gluconate, cetylpyridinium chloride or bromide, and polyhexamethylene biguanide hydrochloride, wherein at least one of the two hydrocarbyl residues comprises 8 to 18 carbon atoms.Type: ApplicationFiled: August 15, 2012Publication date: August 15, 2013Applicant: E I DU PONT DE NEMOURS AND COMPANYInventors: MARK WALLACE SQUIRE, Catherine Mary Chaloner, Sharon Elizabeth Hicks, Kelly Ann Board, Martial Jean-Jacques Pabon
-
Publication number: 20130209574Abstract: Methods for treating water and pulp used in a paper or cardboard manufacturing process. Oxygen and nutrients are added to the water or pulp to increase the activity of aerobic bacteria resulting in a reduction of organic substances such as fatty acids. Alternatively oxygen alone is added to the water or pulp to reduce all both aerobic and anaerobic bacterial activity.Type: ApplicationFiled: August 9, 2012Publication date: August 15, 2013Inventors: Luminita Claudia SCHMID, Joost van de Ven
-
Patent number: 8485821Abstract: A dental tray with a hydrophobic tooth whitening formulation where the tooth whitening formulation is substantially non-water soluble, and a method of using this dental tray to whiten the teeth. The tooth whitening formulation is primarily comprised of a hydrophobic polymer and a peroxide or a peroxide yielding compound. Preferably the hydrophobic polymer is the condensation product of a silicone resin and an organosiloxane. The dental tray is formed to encompass the front and the rear surfaces of the teeth. The dental tray is comprised of a thermoplastic or thermoset polymer. The teeth whitening formulation is placed into the dental tray and the tray placed against the teeth to be whitened. This is for a sufficient period of time to at least partially whiten teeth. This can be a period of time from about 0.5 hour to 2 hours or more.Type: GrantFiled: April 17, 2008Date of Patent: July 16, 2013Assignee: Colgate-Palmolive CompanyInventors: Michael Prencipe, Suman K. Chopra, Michael Collins
-
Publication number: 20130177657Abstract: The invention relates to a Method of generating oxygen and nitric oxide. The method comprises the steps of: guiding an oxygen comprising gas to a primary side of a dense membrane (42), heating the membrane (42) to a temperature at which it is permeable for oxygen, creating a pressure difference between the primary side of the membrane (42) and a secondary side of the membrane (42), wherein a stream of oxygen is generated at the secondary side of the membrane (42) and a stream of oxygen depleted gas is generated at the primary side of the membrane (42). The method according to the invention further comprises the steps of: providing a flow of nitrous oxide comprising gas and heating the nitrous oxide comprising gas to a temperature at which nitric oxide is generated. Thereby, according to the invention, heat generated in the process of operating the membrane is used.Type: ApplicationFiled: September 14, 2011Publication date: July 11, 2013Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.Inventors: Rainer Hilbig, Achim Gerhard Rolf Koerber, Claudia Hannelore Igney
-
Publication number: 20130136801Abstract: This disclosure describes example antimicrobial compositions that may be used in combination with IV port cleansing caps, protective caps, or nasal decolonizer devices. According to another implementations, the disclosure describes that the antimicrobial composition may provide an indication that it has come into contact with a contaminant by bubbling or foam on a surface that is being cleaned. According to another implementation, the disclosure describes that the antimicrobial composition may leave a residual film or barrier to inhibit the recontamination of a surface that has been cleaned.Type: ApplicationFiled: November 28, 2012Publication date: May 30, 2013Applicant: HYPROTEK, INC.Inventor: Hyprotek, Inc.
-
Publication number: 20130108683Abstract: The present invention provides compositions and methods for treating deep partial thickness or full thickness wounds or injuries. The present invention also provides compositions and methods for promoting healing and regeneration of impaired or damaged tissue at a site of such partial thickness or full thickness wounds or injuries, as well as promoting vascularization and angiogenesis in regenerating and/or supportive tissue at such sites.Type: ApplicationFiled: October 24, 2012Publication date: May 2, 2013Applicant: BIOMIMETIC THERAPEUTICS, INC.Inventor: BioMimetic Therapeutics, Inc.
-
Publication number: 20130108610Abstract: The present invention is directed to a method of inhibiting aconitase activity of fungal cells in an individual, the method comprising administering an inhibitor of aconitase activity to the fungal cell in an amount effective to inhibit activity of aconitase by said fungal cells.Type: ApplicationFiled: October 28, 2011Publication date: May 2, 2013Inventors: James Robert SCHWARTZ, Charles Winston Saunders, Robert Scott Youngquist, Jun Xu
-
Publication number: 20130095192Abstract: A method for treating conditions related to lack of blood supply with a lipid based resuscitation fluid is disclosed. The resuscitation fluid contains a lipid component and an aqueous carrier. The lipid component forms an emulsion with the aqueous carrier. The resuscitation fluid can be used to increase the blood pressure and to carry oxygen to tissues. The resuscitation fluid can also be used for preserving the biological integrity of donor organs for transplantation.Type: ApplicationFiled: December 7, 2012Publication date: April 18, 2013Inventor: Cuthbert O. SIMPKINS
-
Publication number: 20130071488Abstract: Disclosed are a two-agent type disinfectant composition for hard articles, which includes a first agent containing a powder mixture (A) and a second agent containing an aqueous hydrogen peroxide solution (B-1), the powder mixture (A) containing an alkali metal salt (A-1) exhibiting basicity when the salt is in the form of an aqueous solution, a water-soluble copper salt (A-2), a compound (A-3) represented by the following formula (1), and a nonionic surfactant (A-4) represented by the following formula (2), and in which the molar ratio of the water-soluble copper salt (A-2) and the compound (A-3) represented by the mixing amount of (A-3)/mixing amount of (A-2) is 3.Type: ApplicationFiled: April 18, 2011Publication date: March 21, 2013Applicant: LION CORPORATIONInventors: Tomonari Suekuni, Takayasu Kubozono, Kodo Horie, Hiromu Sekioda, Tsuyoshi Miyakoshi, Yumi Kurogi
-
Patent number: 8399506Abstract: The present invention relates to the use of combinations of 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile and an oxidizing agent, for eradicating, eliminating or reducing aquatic organisms in ballast water or bilge water whereby 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile and the oxidizing agent are in respective proportions to provide a synergistic effect against fouling organisms. Suitable oxidizing agents are e.g.Type: GrantFiled: August 6, 2007Date of Patent: March 19, 2013Assignee: Janssen Pharmaceutica, NVInventor: Tony Mathilde Jozef Kempen
-
Patent number: 8383532Abstract: The glass flake of the present invention has a composition that includes, in terms of mass %, 60<SiO2?65, 8?Al2O3?15, 47?(SiO2—Al2O3)?57, 1?MgO?5, 18?CaO?30, 0<Li2O?4, 0<(Li2O+Na2O+K2O)?4, and 0?TiO2?5, and that is substantially free from B2O3, F, ZnO, BaO, SrO, and ZrO2.Type: GrantFiled: June 21, 2007Date of Patent: February 26, 2013Assignee: Nippon Sheet Glass Company, LimitedInventors: Kosuke Fujiwara, Akihiro Koyama, Koichi Sakaguchi
-
Patent number: 8349298Abstract: A dental bleaching composition comprises a dental bleaching agent and a polyvinylpyrrolidone thickening agent. The bleaching composition may include water, flavoring agents, a basic substance and desensitizing agents, as desired. Polyvinylpyrrolidone avoids acid etching and chelation of teeth that were problematic in bleaches using carbomer as a thickener. A delivery system for delivering the bleaching composition comprises the aforementioned dental bleaching composition in combination with a moisture-resistant barrier layer such as a dental tray or a flexible strip of material.Type: GrantFiled: October 25, 2007Date of Patent: January 8, 2013Assignee: Ultradent Products, Inc.Inventor: Tianming Chen
-
Publication number: 20130004473Abstract: The present invention provides methods for detecting, analyzing, and identifying biomolecules used to identifying patient with dengue-like symptom who are at risk of DHF. The inventive method comprises detecting in a sample from a subject dengue infected patient one or more biomarkers selected from the group consisting of IL-10, fibrinogen, C4A, immunoglobulin, tropomyosin, and three isoforms of albumin, and which are used in a predictive MARS model to detect patients with risk of developing DHF.Type: ApplicationFiled: June 6, 2012Publication date: January 3, 2013Applicant: The Board of Regents of the University of Texas SystemInventors: Tadeusz Kochel, Josefina Nores Garcia, Allan Brasier, Adrian Recinos, John E. Wiktorowicz, Heidi Spratt, Hyunsu Ju
-
Publication number: 20120321615Abstract: Disclosed herein is a method for predicting the prognosis, the likelihood of metastasis in, or the desirability of administering an aggressive therapy to, a subject with colorectal cancer, comprising determining, in a sample from the subject, the level of phosphorylation of one or more of certain proteins compared to a positive and/or negative reference standard; or the total amount of COX-2 protein compared to a positive and/or negative reference standard. Also described are methods for treating subjects likely to develop metastatic colorectal carcinoma, and pharmaceutical compositions and kits for implementing the methods of the invention.Type: ApplicationFiled: May 25, 2012Publication date: December 20, 2012Inventors: Emanuel Petricoin, III, Lance A. Liotta, Mariaelena Pierobon, Valerie Calvert
-
Publication number: 20120288571Abstract: The present application relates to novel antimicrobial compositions and methods of using said antimicrobial compositions for inhibiting and treating microbial growth, microbial infections, inflammatory diseases, viral diseases, cardiovascular diseases, diabetes and/or conditions that may be regulated or associated with microbial infections, such as cancer.Type: ApplicationFiled: July 20, 2012Publication date: November 15, 2012Applicant: Hyprotek, Inc.Inventors: Patrick O. Tennican, L. Myles Phipps